Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant
Clinical trial NCT03289299 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03289299
- Sponsor
- International Myeloma Foundation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-25
- Primary completion
- 2023-09-26
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.